Improving SVT Discrimination in Single-Chamber ICDs: A New Electrogram Morphology-Based Algorithm
Introduction: Wide‐spread adoption of ICD therapy has focused efforts on improving the quality of life for patients by reducing “inappropriate” shock therapies. To this end, distinguishing supraventricular tachycardia from ventricular tachycardia remains a major challenge for ICDs. More sophisticate...
Saved in:
| Published in | Journal of cardiovascular electrophysiology Vol. 17; no. 12; pp. 1310 - 1319 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Malden, USA
Blackwell Publishing Inc
01.12.2006
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1045-3873 1540-8167 1540-8167 |
| DOI | 10.1111/j.1540-8167.2006.00643.x |
Cover
| Summary: | Introduction: Wide‐spread adoption of ICD therapy has focused efforts on improving the quality of life for patients by reducing “inappropriate” shock therapies. To this end, distinguishing supraventricular tachycardia from ventricular tachycardia remains a major challenge for ICDs. More sophisticated discrimination algorithms based on ventricular electrogram morphology have been made practicable by the increased computational ability of modern ICDs.
Methods and Results: We report results from a large prospective study (1,122 pts) of a new ventricular electrogram morphology tachycardia discrimination algorithm (Wavelet™ Dynamic Discrimination, Medtronic, Minneapolis, MN, USA) operating at minimal algorithm setting (RV coil‐can electrogram, match threshold of 70%). This is a nonrandomized cohort study of ICD patients using the morphology discrimination of the Wavelet algorithm to distinguish SVT and VT/VF. The Wavelet criterion was required ON in all patients and all other supraventricular tachycardia discriminators were required to be OFF. Spontaneous episodes (N = 2,235) eligible for ICD therapy were adjudicated for detection algorithm performance. The generalized estimating equations method was used to remove bias introduced when an individual patient contributes multiple episodes. Inappropriate therapies for supraventricular tachycardia were reduced by 78% (90% CI: 72.8–82.9%) for episodes within the range of rates where Wavelet was programmed to discriminate. Sensitivity for sustained ventricular tachycardia was 98.6% (90% CI: 97–99.3%) without the use of high‐rate time out.
Conclusions: Results from this prospective study of the Wavelet electrogram morphology discrimination algorithm operating as the sole discriminator in the ON mode demonstrate that inappropriate therapy for supraventricular tachycardia in a single‐chamber ICD can be dramatically reduced compared to rate detection alone. |
|---|---|
| Bibliography: | istex:B3D367C3462BBE793920B346E575022FCD65074C ArticleID:JCE643 ark:/67375/WNG-DPK1BCZ7-G Manuscript received 17 April 2006; Revised manuscript received 5 August 2006; Accepted for publication 15 August 2006. This study was sponsored by Medtronic, Inc. Medtronic, Inc. owns Jeffrey Gillberg's patent on the Wavelet Algorithm in the study. Jeffrey Gillberg, Daniel Becker, Katie Schaaf, and Ethan Rooney are Medtronic employees. David Benditt is a shareholder in Medtronic, Inc. and St. Jude Medical, Inc. Arjun Sharma serves as an investigator for Guidant and St. Jude Medical, Inc. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| ISSN: | 1045-3873 1540-8167 1540-8167 |
| DOI: | 10.1111/j.1540-8167.2006.00643.x |